A. Christopher Boyd

Repeated nebulisation of non-viral CFTR gene therapy in patients with cystic fibrosis: a randomised, double-blind, placebo-controlled, phase 2b trial

Eric W.F.W. Alton, David K Armstrong, Deborah Ashby et al. · The Lancet Respiratory Medicine · 2015 · 424 citations · Full text

Pharmacy, Molecular Medicine, Pharmacotherapy +17

Sputum Proteomics in Inflammatory and Suppurative Respiratory Diseases

Robert D. Gray, Gordon MacGregor, Donald Noble et al. · American Journal of Respiratory and Critical Care Medicine · 2008 · 182 citations · Full text

Veterinary Medicine, Molecular Biology, Immunopathology +16

Preparation for a first-in-man lentivirus trial in patients with cystic fibrosis

Eric W.F.W. Alton, Jeffrey M. Beekman, A. Christopher Boyd et al. · Thorax · 2016 · 146 citations · Full text

Pharmacy, Molecular Pharmaceutics, Translational Sciences +13

Sputum Trace Metals Are Biomarkers of Inflammatory and Suppurative Lung Disease

Robert D. Gray, Andrew Duncan, Donald Noble et al. · CHEST Journal · 2009 · 107 citations · Full text

Veterinary Medicine, Pathology, Toxicology +13

A randomised, double-blind, placebo-controlled phase IIB clinical trial of repeated application of gene therapy in patients with cystic fibrosis: Table 1

Eric W.F.W. Alton, A. Christopher Boyd, Seng H. Cheng et al. · Thorax · 2013 · 75 citations · Full text

Medicine, Biotechnology, Molecular Medicine +11